166 related articles for article (PubMed ID: 24776610)
1. Implementation of warnings from Dear Doctor Letters (Rote-Hand-Briefe): an analysis of medication data from a large cohort of elderly patients.
Schächtele S; Tümena T; Gaßmann KG; Fromm MF; Maas R
Dtsch Arztebl Int; 2014 Apr; 111(15):255-63. PubMed ID: 24776610
[TBL] [Abstract][Full Text] [Related]
2. Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data.
de Bardeci M; Greil W; Stassen H; Willms J; Köberle U; Bridler R; Hasler G; Kasper S; Rüther E; Bleich S; Toto S; Grohmann R; Seifert J
Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):65-74. PubMed ID: 35217913
[TBL] [Abstract][Full Text] [Related]
3. Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients.
Schächtele S; Tümena T; Gaßmann KG; Fromm MF; Maas R
PLoS One; 2016; 11(5):e0155649. PubMed ID: 27192430
[TBL] [Abstract][Full Text] [Related]
4. Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs.
Chastang A; Renet S; Corny J; Beaussier H; Petre A; Lillo-Lelouet A; Phan Thi TT; Bézie Y
Int J Clin Pharm; 2019 Feb; 41(1):42-48. PubMed ID: 30610545
[TBL] [Abstract][Full Text] [Related]
5. Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters.
Weatherby LB; Walker AM; Fife D; Vervaet P; Klausner MA
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):211-8. PubMed ID: 11501334
[TBL] [Abstract][Full Text] [Related]
6. Impact of safety-related regulatory action on clinical practice: a systematic review.
Piening S; Haaijer-Ruskamp FM; de Vries JT; van der Elst ME; de Graeff PA; Straus SM; Mol PG
Drug Saf; 2012 May; 35(5):373-85. PubMed ID: 22480319
[TBL] [Abstract][Full Text] [Related]
7. Dual renin-angiotensin-aldosterone blockade: Implementation of published research and Dear Doctor letters in ambulatory care: A retrospective observational study using prescription data.
Angelow A; Ploner T; Grimmsmann T; Walker J; Chenot JF
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):530-537. PubMed ID: 32162407
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the direct healthcare professional communication on citalopram and escitalopram drug utilization for inpatient treatment of anxiety disorders].
Köberle U; Grohmann R; Belz M; Greil W; Degner D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1204-1212. PubMed ID: 36169703
[TBL] [Abstract][Full Text] [Related]
9. The impact of wording in "Dear doctor" letters and in black box labels.
Weatherby LB; Nordstrom BL; Fife D; Walker AM
Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
[TBL] [Abstract][Full Text] [Related]
10. [Impact of Geriatric Drug Guidelines on the Quality Requirement of Elderly Patients].
Fauvelle F; Kabirian F; Domingues A; Tubach F; Gault N; Abbas R
Therapie; 2015; 70(6):515-21. PubMed ID: 26242496
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, seriousness and effect of previous adverse drug reactions on prescribing during acute medical admission.
Acheampong P; Doig JC; Doshi M
Int J Clin Pharm; 2012 Dec; 34(6):871-5. PubMed ID: 22864868
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
[TBL] [Abstract][Full Text] [Related]
13. [Geriatrics in Bavaria-Database (GiB-DAT): Conception, structure and results of implementation (part I)].
Trögner J; Tümena T; Schramm A; Heinrich R; Sieber C;
Z Gerontol Geriatr; 2006 Apr; 39(2):126-33. PubMed ID: 16622634
[TBL] [Abstract][Full Text] [Related]
14. Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021.
Then MI; Tümena T; Sledziewska A; Gaßmann KG; Maas R; Fromm MF
Clin Pharmacol Ther; 2023 Feb; 113(2):435-445. PubMed ID: 36471654
[TBL] [Abstract][Full Text] [Related]
15. Labelling and 'Dear Doctor' letters: are they noncommittal?
van Grootheest AC; Edwards IR
Drug Saf; 2002; 25(15):1051-5. PubMed ID: 12452731
[TBL] [Abstract][Full Text] [Related]
16. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.
Do A; Noohi S; Elie D; Mahdanian AA; Yu C; Segal M; Looper KJ; Rej S
Psychosomatics; 2016; 57(1):57-63. PubMed ID: 26633294
[TBL] [Abstract][Full Text] [Related]
17. [Management of malnutrition in geriatric hospital units in Germany].
Smoliner C; Volkert D; Wirth R
Z Gerontol Geriatr; 2013 Jan; 46(1):48, 50-5. PubMed ID: 22733478
[TBL] [Abstract][Full Text] [Related]
18. Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administration.
Théophile H; Miremont-Salamé G; Robinson P; Moore N; Bégaud B; Haramburu F
Eur J Clin Pharmacol; 2011 Jul; 67(7):681-6. PubMed ID: 21597972
[TBL] [Abstract][Full Text] [Related]
19. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
[TBL] [Abstract][Full Text] [Related]
20. Label-inconsistent use of sibutramine in spontaneous adverse drug reaction reports in Germany.
Seebeck J; Wulf F; Sachs B
Int J Clin Pharmacol Ther; 2008 Jul; 46(7):375-81. PubMed ID: 18793591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
